Influence
January 9, 2020

Regenstrief VP breaking ground in artificial intelligence education in conjunction with National Academy of Medicine, other partners

Eneida Mendonca, Regenstrief Institute, VP for Research DevelopmentRegenstrief Vice President for Research Development Eneida Mendonca, M.D., PhD, is playing a crucial role in the creation of a groundbreaking publication on artificial intelligence in healthcare from the National Academy of Medicine. The document is viewed as a reference for all stakeholders involved in AI and healthcare. Dr. Mendonca is a co-lead on the chapter considering the tradeoffs and unintended consequences of AI and a co-author on the chapter exploring the deployment of AI in clinical settings. She stresses the importance of carefully monitoring the uses and outcomes after AI implementation to correct any negative consequences and the adoption of general IT governance structures to manage AI.  The publication is called “Artificial Intelligence in Health Care: The Hope, The Hype, The Promise, and The Peril.”

Related News

LOINC® biannual stakeholder webinar to highlight latest updates and strategic initiatives

LOINC® biannual stakeholder webinar to highlight latest updates and strategic initiatives

LOINC® from Regenstrief Institute will host a biannual stakeholder meeting on March 25, 2025. During the meeting, held via

AI model predicting two-year risk of common heart disorder can easily be integrated into healthcare workflow

Non-invasive, inexpensive approach provides a practical option for proactive screening INDIANAPOLIS – AFib (short for atrial fibrillation), a common

Kun Huang, PhD

Predicting Alzheimer’s disease subtypes and understanding their molecular characteristics in living patients with transcriptomic trajectory profiling

Published in the Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association. Here is a link to the article.